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Abstract
Background: Surgical "anatomical" repair is the most frequent technique used to correct mitral
regurgitation due to severe myxomatous valve disease. Debate, however, persists on the efficacy
of this technique, as well as on the durability of the repaired valve, and on its functioning and
hemodynamics under stress conditions. Thus, a basal and Dobutamine echocardiographic (DSE)
study was carried out to evaluate these parameters at mid-term follow-up.
Methods and Results: Twenty patients selected for the study (12 men and 8 women, mean age
60 ± 9 years) underwent pre- and post-operative transthoracic echocardiography (TTE) and intra-
operative transesophageal echocardiography (TEE). At mid-term follow-up (20 ± 5 months) all
patients underwent rest TTE and DSE (3 min. dose increments up to 40 microg/Kg/min protocol).
Pre-discharge and one-month TTE showed absence of MR in 11 pts., trivial or mild MR in 9 pts.
and normal mitral valve area and gradients. Mid-term TTE showed decrease in left atrial and
ventricular dimension, in pulmonary artery pressure (sPAP) and grade of MR. During DSE a
significant increase in mitral valve area, maximum and mean gradients, sPAP, heart rate and cardiac
output and a decrease in systolic annular diameter and left ventricular volume were found; in 6 pts.
a transient left ventricular outflow tract obstruction was observed.
Conclusion: Basal and Dobutamine stress echocardiography proved to be valuable tools for
evaluation of mid-term results of mitral valve repair. In our study population, the surgical technique
employed had a favourable impact on several cardiac parameters, evaluated by these methods.
Background
Over the last 30 years many surgical techniques have been
developed to correct mitral regurgitation (MR) in degen-
erative valve disease, to prevent the occurrence of left ven-
tricular outflow tract obstruction (LVOTO) and to
ameliorate the function and durability of the repaired
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mitral valve, particularly in patients with extensive myxo-
matous degeneration of mitral valve leaflets [1-4]. Trans-
esophageal (TEE) and transthoracic (TTE) Doppler
echocardiography are the most useful tools to assess intra-
and post-operative results of mitral valve repair, defining
morphology and function of the repaired valve (area,
mean and peak gradients, annular dynamics, the presence
and grade of residual mitral regurgitation, the presence of
LVOTO) [5-17] Good functional long-term results using
these surgical techniques have been demonstrated [18-
21]. Debate, however, persists over the long-term stability
of correction of MR due to extensive myxomatous degen-
eration of both leaflets [18-24] and over the hemodynam-
ics of the repaired valve under stress conditions. Exercise
echocardiography, considered a physiological stress test,
was used to evaluate the hemodynamic changes and to
unmask valve dysfunction under exercise conditions
[25,26]. However, informations derived from this test are
limited because of the difficulty in obtaining adequate
Doppler signals due to respiratory-related artefacts or to
increased chest wall motion, or because patients are una-
ble or unwilling to perform an exercise protocol. Dob-
utamine stress echocardiography (DSE) has been
proposed as an effective alternative, offering clear images
and optimal Doppler signals [27,28]. However, Dob-
utamine itself can produce a transient LVOTO, not neces-
sarily related to surgical technique[29].
The purpose of the present study was to analyse mid-term
results of mitral valve repair and hemodynamic changes
during DSE in patients referred to our Institution with
extensive myxomatous degenerative mitral valve with the
features of Barlow's disease [30].
Methods
Patient Population
Between October 1998 and January 2004, a total of 330
patients underwent mitral valve repair for pure MR at our
Institution. Of these, 33 patients (10%) had Barlow's dis-
ease [30]. Diagnostic findings obtained preoperatively in
all patients by TTE and TEE were: hypertrofied papillary
muscles, elongation of the subvalvular apparatus, annular
dilatation, bileaflet thickening and redundancy with
floppy valve and prolapse, reduction of the coaptation
area with displacement of the coaptation above the annu-
lar plane. All patients had moderately severe or severe MR.
The diagnosis was confirmed at surgery.
Twenty out of the 33 patients, all living in the region, rep-
resent the study population.
There were 12 men and 8 women, mean age was 60 ± 9
years (range 54–72 yrs.). At admission 11 patients were in
New York Heart Association (NYHA) class II and 9 in class
III. All patients underwent basal pre- and post-operative
TTE, and, at mid-term follow-up (20 ± 5 months), rest TTE
and DSE. All patients underwent pre-operative coronary
angiography. All patients gave their informed consent to
the study protocol. The research protocol was approved by
the locally appointed ethics committee.
Echocardiographic study protocol
At admission into hospital, all patients underwent TTE
and TEE with a HP Sonos 5500 (Agilent Technologies,
Andover, MA, USA), using standard protocols (ASE)[31],
to evaluate left ventricular diameters (LVEDD, LVESD)
and volumes (LVEDV, LVESV), fractional shortening (FS)
and Ejection Fraction, Simpson rule (EF), left atrial
dimension (LA), pathophysiology of mitral valve pro-
lapse and mitral regurgitation, transmitral diastolic flow,
mitral annular diameter, tricuspid regurgitant jet to esti-
mate systolic pulmonary artery pressure (sPAP) by the
Bernoulli principle with a fixed right atrial pressure of 10
mmHg.
Intra-operative TEE was performed before cardiopulmo-
nary bypass (CPB) to confirm pre-operative findings and
after weaning from CPB to control the competence of the
repaired valve, the absence of LVOTO and the adequacy of
trans-mitral flow.
TTE was performed before discharge to confirm intra-
operative findings and to exclude significant pericardial
effusion.
One month later the 20 patients underwent basal TTE;
after a mean of 20 ± 5 months follow-up (range 12–44
months), they underwent basal and Dobutamine TTE (3-
min dose increments, starting from 5 microg/Kg/min
body weight per min and increasing to 10, 20, 30, 40
microg/Kg under continuous electrocardiographic,
echocardiographic and blood pressure monitoring). 2D-
images and Doppler data were recorded at rest, at each
stage, and at 5 min of recovery. The test was discontinued
if any of the following end points was met: 1- target heart
rate (>85% of maximum predicted); 2- intolerable symp-
toms (chest pain or progressive dyspnoea); limiting
asymptomatic side effects (hypertension defined as >220
mmHg of systolic and/or >120 mmHg diastolic blood
pressure; hypotension defined as relative or absolute >30
mmHg decrease blood pressure; supraventricular tachy-
cardia or atrial fibrillation; ventricular tachycardia or fre-
quent, polymorphous premature ventricular beats). The
following aspects were evaluated in basal conditions and
during stress: the competence of mitral valve, maximum
and mean mitral valve gradient by the planimetry of the
diastolic CW Doppler velocity signal, the mitral valve area
by the pressure half-time formula, the annular dimension
from parasternal short-axis view (diastolic and systolic
diameter, area and indexed area), sPAP, systolic andCardiovascular Ultrasound 2007, 5:17 http://www.cardiovascularultrasound.com/content/5/1/17
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diastolic artery blood pressure (PAS, PAD), cardiac output
(by the formula: mitral area × velocity time integral of PW
diastolic mitral flow × heart rate), LVEDV, LVESV, EF, the
possible presence of LVOTO. Measurements were aver-
aged from 5 beats in sinus rhythm or 7 beats in atrial
fibrillation. Images of all echo-Doppler examinations
were performed by one skilled echocardiologist and
stored on video-tape for subsequent analysis.
Surgical Techniques
The mitral valve was repaired during total normothermic
CPB, through conventional midline sternotomy. Myocar-
dial protection was achieved by intermittent anterograde
warm blood cardioplegia. The mitral valve was exposed
by an incision paralleling Waterston's grove. In presence
of ruptured chordae of the posterior mitral leaflet quad-
rangular resection of the flail segment was performed. In
absence of any flail area, part or all the middle scallop of
the posterior leaflet was excised. The remnant of the pos-
terior leaflet was detached from the annulus up to the trig-
ons and the height reduced by the excision of its base so
as to leave a rim no wider than 1 to 1.5 centimeters. The
posterior leaflet was then reattached to the annulus using
a 4-0 Ethibond running suture so as to narrow the poste-
rior annulus (sliding technique). Continuity of the poste-
rior leaflet was obtained suturing the two edges with 4-0
Ethibond running sutures. Posterior annuloplasty using a
segment of a 3 mm ∅ gore-tex graft completed the repair.
The anterior leaflet was approached surgically only in
presence of a flail area due to ruptured chordae by inserc-
tion of gore-tex cordae passed through the papillary mus-
cles and the free margin of the flail leaflet. One patient
with associated CAD underwent myocardial revasculari-
zation.
CPB time was 66 ± 25 min. and aortic cross-clamp was 50
± 19 min.
Statistical analysis
Continuous variables were expressed as mean ± standard
deviation (SD). Differences between continuous variables
at baseline and dobutamine stress-echocardiography were
evaluated with paired Student's t-test. Discrete variables
were summarised by frequency percent and compared
with the chi-square test. One-way analysis of variance
(ANOVA) for repeated measures, with the Bonferroni cor-
rection for multiple testing, was used to measure the vari-
ations of the echocardiographic continuous variables
measured at baseline, at one month and mid-term follow-
up. All analysws were carried out using SPSS 11.0 (SPSS
Inc., Chicago, Illinois, USA). A P value of <0.05 was con-
sidered as statistically significant.
Results
Pre-operative TTE and TEE showed in all 20 patients mod-
erately severe or severe MR. Prolapse of posterior leaflet
associated or not with ruptured chordae was responsible
for MR in all patients. In three patients ruptured chordae
to the anterior leaflet were also present. There was mild
left ventricular enlargement (LVEDD 61 ± 5 mm, LVEDV
127 ± 45 ml) with preserved systolic ventricular function
(EF 60 ± 10%) and mild elevated sPAP (42 ± 16 mmHg).
The most important pre-operative TTE findings are listed
in Table 1.
Intraoperative TEE, before CPB, confirmed pre-operative
findings. After weaning from CPB, all patients were in
sinus rhythm. TEE demonstrated optimal leaflet coapta-
tion, normal diastolic transmitral flow, trivial or absent
MR, absent LVOTO. The mean post-operative stay was 8.5
± 2.5 days. No hospital deaths occurred.
At discharge, TTE showed absence of MR in 11 patients
(55%) and mild or trivial MR in 9 patients (45%), mean
LVEF 50 ± 7%.
Table 1: Pre-operative, one month and follow-up echocardiography (20 pts)
Variable Baseline One month Follow-up p (ANOVA)
LA size (mm) 50 ± 8 46 ± 6 44 ± 6 ns
LVEDD (mm) 61 ± 5 55 ± 6 52 ± 7 0.01
LVESD (mm) 33 ± 6 35 ± 6 34 ± 9 ns
FS (%) 44 ± 7 36 ± 6 35 ± 10 0.008
LVEDV (ml) 127 ± 4 112 ± 33 114 ± 56 ns
LVESV (ml) 55 ± 30 56 ± 21 57 ± 20 ns
EF (%) 60 ± 10 50 ± 7 54 ± 12 0.038
MR grade (3+;4+) 11; 9 0;0 ns 0.001*
(0;1+;2+) 0;0;0 11;8;1 11;8;1 ns**
sPAP (mmHg) 42 ± 16 38 ± 14 30 ± 11 ns
LA = left atrium; LVEDD = left ventricular end diastolic diameter; LVESD = left ventricular end systolic diameter; FS = fractional shortening; LVEDV 
= left ventricular end diastolic volume
LVESV = left ventricular end systolic volume; EF = ejection fraction
MR = mitral regurgitation; sPAP = systolic pulmonary artery pressure
* baseline vs one month
** one month vs follow-upCardiovascular Ultrasound 2007, 5:17 http://www.cardiovascularultrasound.com/content/5/1/17
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One-month TTE showed, in comparison with pre-opera-
tive data, a decrease in LA diameter, LV diameter, volume,
FS, EF, as well as in grade of MR; no change was found in
grade of MR in comparison with discharge results (Table
1).
At the latest follow-up (12 to 44 months after surgery,
mean 20 ± 5 months), all patients were hemodinamically
stable, 16 patients in NYHA class I and 4 in class II.
TTE findings remained unchanged, with the exception of
sPAP, which was significantly reduced to pre-operative
values (42 ± 16 vs 30 ± 11 mmHg) (Table 1).
During DSE mitral valve area increased significantly, as
well as maximum and mean gradients (p < 0.001), sPAP,
HR, CO, whereas systolic annular diameter, LVEDV,
LVESV decreased significantly. No significant difference
was found among other echocardiographic parameters
(Table 2). At peak stress six patients showed a transient
LVOTO, with a peak gradient <40 mmHg in two and >40
mmHg in four (>100 mmHg in two patients) (Figure 1);
one patient showed trivial MR, which was absent at rest.
There were no stress-induced wall motion abnormalities.
Discussion
Many surgical procedures have been developed over the
years to correct valve regurgitation in degenerative mitral
valve disease, to extend feasibility of the repair to the most
complex lesions and to optimize durability [1-4]. Good
results in terms of event-free survival (thromboembolism,
anticoagulant-related haemorrage, endocarditis), mitral
valve function at rest, grade of residual regurgitation and
long-term stability of the repair have been reported [18-
24]. Nevertheless, some potential problems secondary to
the most commonly used surgical technique have been
described. LVOTO is caused by systolic anterior motion of
the anterior mitral leaflet and may occur in presence of
excess tissue of the mitral leaflets and inadequate ring siz-
ing, resulting in a "too small ring for a too large anterior
leaflet" [2]. Impaired diastolic transmitral flow, with sig-
nificant increase in transvalvular pressure gradient and in
sPAP at peak exercise, have recently been reported in
patients treated by the "double-orifice" technique [25].
Impaired diastolic annular dynamics and hampered exer-
cise-related increase in left ventricular ejection fraction
can occur when a rigid ring is employed [32,33]. Calcifi-
cation of the pericardium, when utilized for the posterior
annuloplasty is a possible event [34,35].
TTE and TEE are the most usual and useful tools to evalu-
ate intra- and post-operative results [5-17], while exercise
TTE is usually employed to evaluate valvular dynamics
and function under stress conditions [25,26].
Our study enrolled 20 patients with Barlow's disease and
significant MR. All patients underwent surgical "anatomi-
cal" repair, which was supported by posterior annulo-
plasty, with a segment of a 3 mm ∅ gore-tex tube. This
technique has the purpose of preserving the morphologi-
cal, non planar configuration of the mitral annulus, main-
taining its physiology, respecting anatomical and
functional valvular-ventricular interaction and preventing
the occurrence of LVOTO.
Our results confirmed the efficacy, the stability and dura-
bility of mitral valve repair using this technique, as dem-
onstrated by the intra-operative assessment and the one-
month and mid-term echocardiographic follow-up. Fur-
ther support to the good surgical result was the significant
improvement in functional class which occurred in all
patients. Many published series of follow-up data have
shown that mitral valve repair is a safe and reproducible
technique, that results are stable, with low risk of re-oper-
ation, decrease in LVESD and LVESV and improvement of
LV function is achieved in most patients (with NYHA
functional class I-II). Moreover, all these studies have
demonstrated that together with the elimination of valve
regurgitation lower complication rates than with mitral
valve replacement is achieved [18-21].
In our study DSE was performed with the aim to evaluate
haemodynamic response under stress conditions and
elicit the possible dysfunction of the repaired mitral valve.
During stress, functional mitral valve area and mean
transvalvular gradient increased significantly, as well as
sPAP, HR and CO. There was also an increase in annular
area, annular diastolic diameter and annular area index,
which was not significant. Systolic annular dimension,
LVEDV and LVESV decreased significantly. These data,
because of the small sample, are not conclusive, but
clearly demonstrate evidence of good valve function, not
only at rest but also during stress, further supported by a
rise in mitral valve gradients and sPAP, as consequence of
haemodynamic effects of Dobutamine, which did not
reach pathologic levels. Previous study on the normal
mitral valve physiology clearly demonstrated that exercise
induces increase of transmitral flow by an increase in
mean diastolic cross-sectional area [36]. Consequently,
maintenance or a minimal limitation of the physiologic
diastolic motion of the mitral valve annulus is an impor-
tant component of surgical repair if unrestrictive transval-
vular flow has to be maintained during high flow
cardiocirculatory conditions. Correlation between incre-
mental dose of Dobutamine and increase in transmitral
peak flow velocity has recently been demonstrated [37].
In patients who underwent mitral valve repair, Borghetti
demonstrated, using supine bicycle exercise, absence of
significant MR and increase in transmitral flow velocities,
LVEF and mitral annular dynamics (evaluated by mitralCardiovascular Ultrasound 2007, 5:17 http://www.cardiovascularultrasound.com/content/5/1/17
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Rest and Dobutamine echocardiogram following mitral valve repair Figure 1
Rest and Dobutamine echocardiogram following mitral valve repair. Panel A: Top: Two-dimensional echo, apical 4-
chamber view: normal coaptation of mitral leaflets; systolic anterior movement (SAM) is absent. Middle: M-Mode echo, mitral 
valve: normal coaptation of mitral leaflets. Bottom: Two-dimensional echo, PW Doppler in left outflow tract (LVOT):normal 
peak systolic velocity. Panel B: Top: Two-dimensional echo, apical 4-chamber view: SAM of anterior mitral leaflet is present. 
Middle: M-Mode echo, mitral valve; SAM is present. Bottom: Two-dimensional echo, PW Doppler in LVOT: elevated peak mid-
systolic velocity corresponding to 46 mmHg outflow gradient.Cardiovascular Ultrasound 2007, 5:17 http://www.cardiovascularultrasound.com/content/5/1/17
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annular motion) during peak exercise condition, with
more favourable results in the subgroup of patients who
had annuloplasty performed with autologous pericar-
dium [35]. Other studies have been performed in animal
models or in computational models to evaluate mitral
annular three-dimensional dynamics and transvalvular
gradients using myocardial markers and Doppler echocar-
diography [28]. Though interesting the results, the major
limitations of these studies are inherent to the animal or
to the laboratory models used which may not be trans-
lated to the clinical setting.
With the technique we describe, mitral annular dynamics
have been preserved as demonstrated by the mild, but not
significant, increase in diastolic and significant decrease in
systolic diameters and by the increase of annular area and
annular area index.
During DSE only one patient showed trivial MR which
was absent at rest and six patients showed transient
LVOTO: two patients with intra-ventricular peak gradient
< 40 mmHg, two between 40 and 100 mmHg and two >
100 mmHg. The appearance of LVOTO during DSE in
non-operated patients was first described in 1992 [38]. A
statistical correlation with a high basal EF and fall in systo-
lic blood pressure during stress has been demonstrated
[38] as well as a correlation with left ventricular geometry
and systolic volume and FS [39]. In a different clinical set-
ting other Authors found an incidence of LVOTO of 7.5%
and a correlation with increased myocardial contractility,
systolic anterior motion of the anterior leaflet, decreased
venous return to the left ventricle, and peculiar character-
istic of the left ventricular geometry [29]. In repaired
mitral valve the occurrence of basal LVOTO (a 4–6% inci-
dence) has been reported by several Authors [10-14], as a
consequence of surgically induced changes, particularly
reduction in circumference of mitral annulus, prosthetic
ring implant and narrowing of the mitro-aortic angle,
which are responsible for an overlapping of the usually
distinct two functional compartments: inflow and out-
flow. Recently, a correlation between LVOTO appearance
and a too small circumference of the mitral annulus fol-
lowing valve repair compared to the combined heights of
the two leaflets, being the anterior mitral leaflet height a
more important factor, has been demonstrated [17].
Jebara and Coll found an incidence of LVOTO very low
(2.4%) when the "sliding technique and prosthetic ring
annuloplasty", was used [15]. Transient LVOTO has been
observed during exercise test, associated with mitral systo-
lic anterior motion and significant intraventricular gradi-
ent, in patients with repaired mitral valve [25]. The
absence of LVOTO in basal condition in our series sup-
ports the need at surgery of reducing the height of the pos-
terior leaflet, particularly in patients with extensive
myxomatous degeneration of both leaflets. The induced
and transient LVOTO during DSE is correlated to pharma-
cological hemodynamcs changes.
Study limitation
A limitation of the present study is the relatively small
sample size (only 20 patients); therefore the statistical
analysis could have been adversely influenced by inappro-
priate study sample.
A long-term clinical and echocardiographic follow-up is
necessary to confirm the stability of the repaired valve.
Table 2: Baseline and dobutamine stress echocardiography (20 pts)
Variable Baseline Stress P
Mitral valve area (cm2) 2.9 ± 0.7 4.5 ± 2 <0.001
Mx PG (mmHg) 7.2 ± 1.9 14 ± 3.7 0.4
Md PG (mmHg) 2.7 ± 1 6.3 ± 1.5 <0.001
Mitral Annulus, systole (mm) 41 ± 3.4 38 ± 2.2 <0.001
Mitral Annulus, diastole (mm) 43.7 ± 3.3 45.7 ± 3 0.4
Mitral Annulus, area (cm2) 3.4 ± 0.4 3.7 ± 0.6 0.1
IAA 1.9 ± 0.3 2.1 ± 0.3 0.1
sPAP (mmHg) 33.5 ± 10 41.6 ± 12 0.03
MR grade (1+/2+) 9/20 10/20 ns
HR (beats/min) 75 ± 19 133 ± 22 <0.001
SBP (mmHg) 124 ± 14 127 ± 24 0.6
DBP (mmHg) 76 ± 9 70 ± 9 0.1
CO (L/min) 3.9 ± 1.9 6.6 ± 2.8 <0.001
EF (%) 50 ± 11 52 ± 12 0.3
LVEDV (ml) 114 ± 58 103 ± 56 0.05
LVESV (ml) 61 ± 50 54 ± 48 0.04
LVOTO (%) 0 30 <0.001
Mx PG: maximum pressure gradient; Md PG: mean pressure gradient; IAA: indexed annular area; sPAP: systolic pulmonary artery pressure; MR: 
mitral regurgitation; HR: heart rate; SBP: systolic blood pressure; DBP: diastolic blood pressure; CO: cardiac output; EF: ejection fraction; LVEDV: 
left ventricular end diastolic volume; LVESV: left ventricular end systolic volume; LVOTO: patients with left ventricular outflow tract obstruction.Cardiovascular Ultrasound 2007, 5:17 http://www.cardiovascularultrasound.com/content/5/1/17
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Conclusion
Transthoracic and transesophageal echocardiography
have a strategic role in pre-, intra- and post-operative
assessment of the mitral valve, particularly in patients
with Barlow's disease. In the present study, TTE and DSE
proved to be valuable tools for evaluation of mid-term
results of "anatomical" repair of MR due to extensive
myxomatous degeneration of both leaflets.
The surgical technique employed had a favourable impact
on several parameters. The majority of patients showed
competent mitral valve or mild-trivial MR, with no path-
ological modification under stress conditions. Further-
more, remarkable reduction in LA and LV dimension was
clearly demonstrated at follow-up.
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